Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • marco12345
    Member
    • Mar 2013
    • 19

    #1

    heterozygosity and allele balance in NGS doubt

    Hi,

    I have data from a target enrichment on a few human genes, of course sequenced through NGS. Enrichment, sequencing and data analysis were performed by a private genomic service.

    In the VCF file some variants show an allele frequency around 1-2%, but their locus is called as heterozygous. Isn't the variant presence too low to call it as heterozygous?

    I am not too acquainted with these kind of analysis, so I am a little confused by this. Could someone please help me out?

    Thanks a lot in advance.

    Marco
  • colindaven
    Senior Member
    • Oct 2008
    • 417

    #2
    Why not do some filtering on the data ? Think vcfutils will do this for you.

    Generally people might take variants with an allele frequency cutoff of around 22% to be genuine heterozygotes. Sometimes you get a nice 50/50 ratio, but you miss out on a lot of data if you stick to very strict thresholds.

    Certainly reporting 1-2% AF as heterozygotes is not great analysis.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Yesterday, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    71 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...